EQUITY RESEARCH MEMO

Evolution Research Group

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)60/100

Evolution Research Group (ERG) is a private, independently held clinical research site company founded in 2000 and headquartered in Little Falls, New Jersey. With a network of specialized sites, ERG has deep expertise in complex therapeutic areas including psychiatry, neurology, pain, addiction, sleep disorders, NASH, diabetes, and tobacco, and has expanded to offer full-service CRO capabilities. The company is well-positioned to capitalize on the growing demand for decentralized and specialized clinical trials, particularly in CNS and metabolic diseases. Despite being private and lacking disclosed financials, ERG's established presence and diversified service offering provide a solid foundation for growth. The company's conviction score is moderate, reflecting its strong niche but limited visibility on near-term catalysts.

Upcoming Catalysts (preview)

  • Q3 2026Expansion into new therapeutic areas or geographic markets65% success
  • Q4 2026Strategic partnership or acquisition to enhance CRO capabilities50% success
  • Q2 2026Adoption of digital health technologies to improve trial efficiency70% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)